Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Pharmacogenetic considerations in the management of HIV infection
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacogenetic considerations in the management of HIV infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Pharmacogenetics
91%
HIV Infections
70%
HIV
46%
Pharmaceutical Preparations
33%
HLA-B57 antigen
23%
abacavir
19%
Pharmacogenomic Testing
17%
Drug Therapy
15%
Cytochromes
15%
ATP Binding Cassette Transporter, Subfamily B, Member 1
14%
Genetic Polymorphisms
14%
HLA Antigens
13%
Combination Drug Therapy
13%
Drug-Related Side Effects and Adverse Reactions
12%
Single Nucleotide Polymorphism
11%
Hypersensitivity
10%
Pharmacokinetics
10%
Genotype
9%
Morbidity
7%
Enzymes
7%
Mortality
6%
Genes
5%
Proteins
4%
Therapeutics
2%
Chemical Compounds
Antiretroviral
100%
Drug
42%
Genetic Polymorphism
15%
Pharmacological Metabolism
15%
Anti HIV
12%
Cytochrome
8%
Antigen
8%
Nucleotide
8%
Pharmacokinetics
7%
Protein
4%